Polocaine(R) -Mpf (Mepivacaine Hci) NDC 51662-1403

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1403Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1403Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1403-1	51662140301	30 mL in 1 VIAL, SINGLE-DOSE (51662-1403-1)Marketed from Dec 10, 2019
51662-1403-3	51662140303	25 POUCH in 1 CASE (51662-1403-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1403-2) / 30 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 8, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Polocaine(R) -Mpf (Mepivacaine Hci)
Generic name (nonproprietary): polocaine(r) -mpf (mepivacaine hci)
Active ingredients: Mepivacaine hydrochloride — 10 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089406
Marketing start: Dec 10, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1403_101eb629-ce5c-2499-e063-6394a90ad55cSPL ID 101eb629-ce5c-2499-e063-6394a90ad55cSPL set ID 996381e2-485b-9434-e053-2a95a90a08e1RxCUI 1866503UNII 4VFX2L7EM5UPC 0363323260019
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662140301 followed by a unit qualifier and the quantity

Package 51662-1403-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE POLOCAINE (Mepivacaine HCl Injection, USP), is indicated for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. The routes of administration and indicated concentrations for mepivacaine are: See DOSAGE & ADMINISTRATION for additional information. Standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of mepivacaine. INDICATIONS & USAGE

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 089406

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 089406
Product	Strength	Form · route	Labeler	Product NDC
Polocaine-MPFmepivacaine hydrochloride	Mepivacaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration	Fresenius Kabi USA, LLC	63323-260